|
1
|
Lowe KA, Chia VM, Taylor A, O'Malley C,
Kelsh M, Mohamed M, Mowat FS and Goff B: An international
assessment of ovarian cancer incidence and mortality. Gynecol
Oncol. 130:107–114. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Foley OW, Rauh-Hain JA and del Carmen MG:
Recurrent epithelial ovarian cancer: an update on treatment.
Oncology (Williston Park). 27:288–294. 2982013.PubMed/NCBI
|
|
3
|
Geurts SM, de Vegt F, van Altena AM, van
Dijck JA, Tjan-Heijnen VC, Verbeek AL and Massuger LF: Considering
early detection of relapsed ovarian cancer: a review of the
literature. Int J Gynecol Cancer. 21:837–845. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Santillan A, Garg R, Zahurak ML, Gardner
GJ, Giuntoli RL II, Armstrong DK and Bristow RE: Risk of epithelial
ovarian cancer recurrence in patients with rising serum CA-125
levels within the normal range. J Clin Oncol. 23:9338–9343. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Takebe N, Nguyen D and Yang SX: Targeting
notch signaling pathway in cancer: Clinical development advances
and challenges. Pharmacol Ther. 141:140–149. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rose SL, Kunnimalaiyaan M, Drenzek J and
Seiler N: Notch 1 signaling is active in ovarian cancer. Gynecol
Oncol. 117:130–133. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jung SG, Kwon YD, Song JA, Back MJ, Lee
SY, Lee C, Hwang YY and An HJ: Prognostic significance of Notch 3
gene expression in ovarian serous carcinoma. Cancer Sci.
101:1977–1983. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cancer Genome Atlas Research Network, .
Integrated genomic analyses of ovarian carcinoma. Nature.
474:609–615. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tothill RW, Tinker AV, George J, Brown R,
Fox SB, Lade S, Johnson DS, Trivett MK, Etemadmoghadam D, Locandro
B, et al: Novel molecular subtypes of serous and endometrioid
ovarian cancer linked to clinical outcome. Clin Cancer Res.
14:5198–5208. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ferriss JS, Kim Y, Duska L, Birrer M,
Levine DA, Moskaluk C, Theodorescu D and Lee JK: Multi-gene
expression predictors of single drug responses to adjuvant
chemotherapy in ovarian carcinoma: Predicting platinum resistance.
PLoS One. 7:e305502012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ganzfried BF, Riester M, Haibe-Kains B,
Risch T, Tyekucheva S, Jazic I, Wang XV, Ahmadifar M, Birrer MJ,
Parmigiani G, et al: CuratedOvarianData: Clinically annotated data
for the ovarian cancer transcriptome. Database (Oxford).
2013:bat0132013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Simon R, Lam A, Li MC, Ngan M, Menenzes S
and Zhao Y: Analysis of gene expression data using BRB-ArrayTools.
Cancer Inform. 3:11–17. 2007.PubMed/NCBI
|
|
13
|
Gillet JP, Wang J, Calcagno AM, Green LJ,
Varma S, Bunkholt Elstrand M, Trope CG, Ambudkar SV, Davidson B, et
al: Clinical relevance of multidrug resistance gene expression in
ovarian serous carcinoma effusions. Mol Pharm. 8:2080–2088. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cheon DJ, Tong Y, Sim MS, Dering J, Berel
D, Cui X, Lester J, Beach JA, Tighiouart M, Walts AE, et al: A
collagen-remodeling gene signature regulated by TGF-β signaling is
associated with metastasis and poor survival in serous ovarian
cancer. Clin Cancer Res. 20:711–723. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dai W, Teodoridis JM, Zeller C, Graham J,
Hersey J, Flanagan JM, Stronach E, Millan DW, Siddiqui N, Paul J,
et al: Systematic CpG islands methylation profiling of genes in the
wnt pathway in epithelial ovarian cancer identifies biomarkers of
progression-free survival. Clin Cancer Res. 17:4052–4062. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang X, Fu Y, Chen X, Ye J, Lü B, Ye F, Lü
W and Xie X: The expressions of bHLH gene HES1 and HES5 in advanced
ovarian serous adenocarcinomas and their prognostic significance: A
retrospective clinical study. J Cancer Res Clin Oncol. 136:989–996.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ivan C, Hu W, Bottsford-Miller J, Zand B,
Dalton HJ, Liu T, Huang J, Nick AM, Lopez-Berestein G, Coleman RL,
et al: Epigenetic analysis of the Notch superfamily in high-grade
serous ovarian cancer. Gynecol Oncol. 128:506–511. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kang KW, Lee MJ, Song JA, Jeong JY, Kim
YK, Lee C, Kim TH, Kwak KB, Kim OJ and An HJ: Overexpression of
goosecoid homeobox is associated with chemoresistance and poor
prognosis in ovarian carcinoma. Oncol Rep. 32:189–198.
2014.PubMed/NCBI
|
